100% correct plus this is compounded by having 7 years market exclusivity , we can roughly estimate 2kg's of Pharmapantel manufactures circa 35,000 tablets ... I have no idea what PAA or Big Pharma may charge to market for Neuro-Pantel but Riluzole is $637 USD for 60 Tablets and Amylyx is $12,000 for 28 days worth of meds..
Big Pharma definitely monitor FDA Applications as these are closest to market , if Pfizer are currently revenueing $1.2B you can be sure the PAA MPL FDA Application for ODD will not go unnoticed.
90 Days Regulatory Period for ODD,,,, should be early March.. BOOM
Ann: PAA completes Phase 1 and files for Orphan Drug Designation, page-36
-
- There are more pages in this discussion • 395 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $58.40K | 305.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 115000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 86074 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |